![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_5206c9986b5473d76f23db6e34764197.svg) | Raclopride | Ki | 5.1 [1], 8.7 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_822b68838fffd6964517f5b8f84eafba.svg) | Dopamine | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_3e94330ba1527a829fecddbee5acde55.svg) | Apomorphine | IC50 | 25.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_227772c6b35181ad4f999c7ec25d9175.svg) | Harmine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_5d04839800fb36d0809dc154554e3949.svg) | Butaclamol | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_2b9338803c8da7a9eb261bc345ef6993.svg) | 5-OH-Dpat | IC50 | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_f04bd877f888b388d137e4aebca3aee9.svg) | Harmalan | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_25f5e25b0dad5fba18d7a0a972a7ad5f.svg) | Naluzotan | Ki | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_a452a79e7fbf7c22f9bc9c0b9f3a4125.svg) | Chloroethylnorapomorphine | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_bbdac4336b2d4521f766b1b0ac7670f2.svg) | 6-Methoxyharmalan | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_de89ceb665e5026d1a6a5be2ae5780ef.svg) | (S)-1-Propyl-3-(3-propyl-phenyl)-piperidine | Ki | 57.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_3cbad8d932a0cd6fee4e415b20642d53.svg) | Fluororaclopride | Ki | 159.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_6b93ec5c08fa753d56c882c9f8ae85c8.svg) | (S)-3-(3-Ethynyl-phenyl)-1-propyl-piperidine | Ki | 334.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_917f798403567f7d0a4bfca2d4bbf1f2.svg) | (S)-3-(3-Methylsulfanyl-phenyl)-1-propyl-piperidine | Ki | 49.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_f17f804a6f7c86480707d7785474ce56.svg) | (S)-3-Phenyl-1-propyl-piperidine | Ki | 222.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_cd2d073affa165e8253e56876c0a44a9.svg) | (S)-3-(3-Bromo-phenyl)-1-propyl-piperidine | Ki | 106.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_022e3ed788989116c32ae65407cc9a34.svg) | 6-Benzyloxymethyl-5-[4-(4-chloro-benzylamino)-phenyl]-pyrimidine-2,4-diamine | IC50 | 33000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_156c1b6061463bd870783cdadd55a418.svg) | Trifluoromethanesulfonic acid 3-[(3S)-1-propyl-3-piperidinyl]phenyl ester | Ki | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_14befca37382b5d0e7fae350d9db2437.svg) | 3-((S)-1-Propyl-piperidin-3-yl)-benzaldehyde | Ki | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_ca4a63d8ce1f4a34f8bf47c7b6f88e78.svg) | Trifluoro-methanesulfonic acid 3-((S)-1-phenethyl-piperidin-3-yl)-phenyl ester | Ki | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_e44b2235504bbd241954e1a05460e2ae.svg) | Toluene-4-sulfonic acid 3-((S)-1-propyl-piperidin-3-yl)-phenyl ester | Ki | 162.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_08d58de9eeee12e0e99340609a35668f.svg) | [4-[(3S)-1-Propylpiperidin-3-yl]-2-(trifluoromethylsulfonyloxy)phenyl] trifluoromethanesulfonate | Ki | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_2a26e3adb0bb1e203c0e20b7698094a0.svg) | Trifluoro-methanesulfonic acid 4-((S)-1-propyl-piperidin-3-yl)-phenyl ester | Ki | 1736.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_5f326b4faf3022a7fcd04561e539dc85.svg) | (S)-1-Propyl-3-m-tolyl-piperidine | Ki | 430.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_8b534ece714d8099f4710c1c775aa1bc.svg) | [(3As,9bR)-3-prop-2-enyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl] trifluoromethanesulfonate | Ki | 1900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_5952845286618c52f3f4737b688f630c.svg) | Trifluoro-methanesulfonic acid 2-((S)-1-propyl-piperidin-3-yl)-phenyl ester | Ki | 315.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_367fe4cbf2e533abd06fbf76151c17bc.svg) | 2-[2-[5-[2-(Benzyloxy)phenyl]-3-thienyl]phenyl]cyclopropane-1-carboxylic acid | Ki | 120.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_688e5187c25a2e7eb80c6223a3e7777b.svg) | 5-(4-(2-Quinolylmethoxy)phenyl)-6-(4-fluorophenyl)pyridine-2(1H)-one | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_e4c9842916a1b21875160dcc9ae06b56.svg) | 3,5-Dichloro-N-[[(2S)-1-(4-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 88.5 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_c5e5f9802f34fd83bfcfadd756a1b070.svg) | 3,5-Dichloro-2-hydroxy-6-methoxy-N-[[(2S)-1-propylpyrrolidin-2-yl]methyl]benzamide | Ki | 17.3 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_e3b1047c3537d46269d1dafbd6f2c621.svg) | N-[[(2S)-1-Butylpyrrolidin-2-yl]methyl]-3,5-dichloro-2-hydroxy-6-methoxybenzamide | Ki | 41.1 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_db3daef5b6039495f3e1c4a4fdec11fb.svg) | 3,5-Dichloro-N-[[(2S)-1-(3-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 2610.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_2e985a180476b533e7a35c54a27be379.svg) | 3,5-Dichloro-N-[[(2S)-1-(3-fluoropropyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 130.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_6b40e65bf139c6d89e2a0ca7fd5ff4c0.svg) | (3-Prop-2-enyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl) trifluoromethanesulfonate | Ki | 125.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_bfcdb24881a0dd6923e042462819be2f.svg) | (3-Propyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl) trifluoromethanesulfonate | Ki | 89.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_8d5a41ec10bb2d43b4820c8120eaada8.svg) | (4-Propyl-2,3,4a,5,6,10b-hexahydro-1H-benzo[f]quinolin-7-yl) trifluoromethanesulfonate | Ki | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_b47166a9bd78b71327ec4128af9e7a2d.svg) | 1-[1-[(2-Chlorophenyl)methyl]-2-oxopyridin-3-yl]-3-(3-ethylphenyl)urea | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_78ab54ffa2deab3fc47db632d61015a6.svg) | N-(4-Aminophenyl)sulfonyl-N'-ethyl-2,3-diazaspiro[4.4]non-3-ene-2-carboximidamide | Ki | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-receptor_1beb54f268a0cc0e6c785da381588bba.svg) | 3,5-Dichloro-N-[[(2R)-1-(3-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | Ki | 2620.0 [1] |